Inj, invega hafyera/trinza
Products billed under this code include Invega Hafyera, Invega Trinza.
Payment limit per 1MG, by effective quarter, 3Q23 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under this code include Invega Hafyera, Invega Trinza.
Payment limit per 1MG, by effective quarter, 3Q23 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Invega Hafyera | Janssen Pharmaceuticals, Inc. | 50458-0611-01 | 1092 | $14,464.632 |
| Invega Hafyera | Janssen Pharmaceuticals, Inc. | 50458-0612-01 | 1560 | $20,663.76 |
| Invega Trinza | Janssen Pharmaceuticals, Inc. | 50458-0606-01 | 273 | $3,616.158 |
| Invega Trinza | Janssen Pharmaceuticals, Inc. | 50458-0607-01 | 410 | $5,430.86 |
| Invega Trinza | Janssen Pharmaceuticals, Inc. | 50458-0608-01 | 546 | $7,232.316 |
| Invega Trinza | Janssen Pharmaceuticals, Inc. | 50458-0609-01 | 819 | $10,848.474 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $13.246 | −$0.016 | 1MG | Inj, invega hafyera/trinza | v1, posted September 17, 2026 |
| 3Q26 | $13.262 | +$0.313 | 1MG | Inj, invega hafyera/trinza | v1, posted September 15, 2026 |
| 2Q26 | $12.949 | −$0.042 | 1MG | Inj, invega hafyera/trinza | v1, posted September 15, 2026 |
| 1Q26 | $12.991 | −$0.005 | 1MG | Inj, invega hafyera/trinza | v1, posted September 15, 2026 |
| 4Q25 | $12.996 | +$0.041 | 1MG | Inj, invega hafyera/trinza | v1, posted September 8, 2026 |
| 3Q25 | $12.955 | +$0.283 | 1MG | Inj, invega hafyera/trinza | v1, posted March 10, 2026 |
| 2Q25 | $12.672 | +$0.05 | 1MG | Inj, invega hafyera/trinza | v1, posted March 10, 2026 |
| 1Q25 | $12.622 | −$0.035 | 1MG | Inj, invega hafyera/trinza | v1, posted December 19, 2025 |
| 4Q24 | $12.657 | +$0.125 | 1MG | Inj, invega hafyera/trinza | v1, posted June 11, 2025 |
| 3Q24 | $12.532 | +$0.347 | 1MG | Inj, invega hafyera/trinza | v1, posted June 11, 2025 |
| 2Q24 | $12.185 | −$0.025 | 1MG | Inj, invega hafyera/trinza | v1, posted March 11, 2025 |
| 1Q24 | $12.21 | +$0.011 | 1MG | Inj, invega hafyera/trinza | v1, posted December 19, 2024 |
| 4Q23 | $12.199 | +$0.091 | 1MG | Inj, invega hafyera/trinza | v1, posted October 10, 2024 |
| 3Q23 | $12.108 | – | 1MG | Inj, invega hafyera/trinza | v1, posted June 5, 2024 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.